Monday, November 27, 2017

Biolinq Raises $10M

San Diego-based Biolinq, a startup developing wireless-enabled, biosensor patches aimed at continually monitoring blood glucose levels, has raised $10M in a Series A funding, the company said this morning. The funding was led by M Ventures, and also included Hikma Ventures, Grey Sky Venture Partners, Three Leaf Ventures, LifeSci Venture Partners, as well as angels. Biolinq said its product will allow patients with diabetes to continuously monitor their blood glucose without the pain and hassle of traditional continuous glucose monitoring systems. Biolinq is led by CEO Jared Tangney. As part of the funding Dan Bradbury, the former CEO of Amylin Pharmaceuticals, has joined as executive chairman, and M Ventures' Edwards Kliphuis, along with Hikma Ventures' Lana Ghanem have both joined the company's board.